orphan-disease-venture-scoutlisted
Install: claude install-skill rare-disease-atlas/orphan-disease-venture-scout-skill
# Orphan Disease Venture & Translational Scout (`v1.6.0` + Open Agent Nectar Suite)
Helps founders, computational biologists, public-health researchers, and biotech investors identify, stress-test, and diligence capital-efficient startup and translational research wedges in underserved rare diseases—anchored on **Paired Flagship Deep-Dives** in **Clonal `JAK2 V617F+` Primary Myelofibrosis (`jak2-myelofibrosis`)** and **Reversible `Autoimmune Myelofibrosis` (`autoimmune-myelofibrosis`, AIMF + Dual Transfusional & IL-6/Hepcidin Iron Overload)**, plus 4 comparative hematology/immunology cohorts (`vexas-syndrome`, `castleman-disease`, `systemic-mastocytosis`, `telomere-biology-disorders`) and live federated diligence across all **7,000+ orphan diseases**.
## When to Use This Skill
- A user asks **what high-impact biotech, AI-bio, computational biology, or public-health problem/startup** to build—especially without a wet lab or with <$250K–$2.5M in initial capital.
- A user wants to **stress-test or red-team a candidate drug target, allosteric binder/PROTAC, diagnostic algorithm, or orphan venture thesis** against clinical trial failure modes, `JH2` vs `JH1` selectivity traps, or `AIMF` vs Triple-Negative PMF pathology discordance.
- A user wants to evaluate **rare/orphan disease unit economics** (FY2026 `$4,682,003` FDA PDUFA fee waiver, 7-year market exclusivity, 25% ODTC, `$100M–$158M` Rare Pediatric Disease PRV comps, venture-philanthropy SPVs, SBIR/STTR non-dilutive grant